Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer
Article in RSC Medicinal Chemistry (January 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Harnessing G-quadruplex ligands for lung cancer treatment: A comprehensive overview
Article in Drug Discovery Today (October 2023)
Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures
Article in International Journal of Pharmaceutics (September 2023)